Studies examining patients with remitted major depressive disorder found that ATD induced a transient return of depressive symptoms36,37, along with decreased 5-HT2 receptor binding of [18F]Setoperone in patients36, and augmented regional cerebral glucose utilization in patients but not in controls37. The gene discussed is HTR2A; the disease is major depressive disorder.